Literature DB >> 1143359

Uptake of dopamine into fractions of pig caudate nucleus homogenates.

A Philippu, H Matthaei, H Lentzen.   

Abstract

Homogenates of the caudate nucleus of the pig were submitted to differential centrifugation. The 20000 g and 80000 g fractions were isolated and a part of them was osmotically shocked. The highest dopamine content per mg protein was found in the intact 80000 g fraction. Incubation experiments with the intact and the osmotically shocked fractions at 25 degrees C revealed that the particles of the intact 20000 g fraction took up dopamine, the influx of the amine was not enhanced by addition of ATP and magnesium to the incubation medium. On the other hand after osmotic shock the uptake of dopamine into the particles of this fraction was greatly enhanced by addition of ATP and magnesium. The uptake of dopamine into the particles of both intact and osmotically shocked 80000 g fractions was likewise enhanced by ATP and magnesium. The uptake in all fractions was not influenced by ouabain. The influx of dopamine into the particles of the intact 80000 g fraction was competitively inhibited by reserpine (Ki0.96 x 10-8M) and prenylamine (Ki1.74 x 10-8M). It is concluded that the intact 20000 g fraction contains intact synaptosomes; the uptake of dopamine is independent of the presence of ATP and magnesium. The shocked 20000 g fraction and the 80000 g fractions contain synaptic vesicles; the uptake of dopamine into these vesicles is enhanced by ATP and magnesium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1143359     DOI: 10.1007/bf00510449

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  A Mg-ATP dependent storage mechanism in the amine granules of the adrenal medulla.

Authors:  A CARLSSON; N A HILLARP; B WALDECK
Journal:  Med Exp Int J Exp Med       Date:  1962

2.  The sodium-stimulated adenosine-triphosphatase activity and other properties of cerebral microsomal fractions and subfractions.

Authors:  A SCHWARTZ; H S BACHELARD; H McIL WAIN
Journal:  Biochem J       Date:  1962-09       Impact factor: 3.857

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Dopamine and noradrenaline transport into subcellular vesicles of the striatum.

Authors:  A Philippu; J Beyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Uptake of norepinephrine by the isolated hypothalamic vesicles.

Authors:  A Philippu; U Burkat; H Becke
Journal:  Life Sci       Date:  1968-10-01       Impact factor: 5.037

6.  Release of dopamine from subcellular particles of the striatum.

Authors:  A Philippu; W Heyd
Journal:  Life Sci       Date:  1970-04       Impact factor: 5.037

7.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15

8.  THE SUBCELLULAR LOCALIZATION OF DOPAMINE AND ACETYLCHOLINE IN THE DOG CAUDATE NUCLEUS.

Authors:  R LAVERTY; I A MICHAELSON; D F SHARMAN; V P WHITTAKER
Journal:  Br J Pharmacol Chemother       Date:  1963-12
  8 in total
  6 in total

1.  Uptake of serotonin, gamma-aminobutyric acid and histamine into synaptic vesicles of the pig caudate nucleus.

Authors:  A Philippu; H Matthaei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Competition of some biogenic amines for uptake into synaptic vesicles of the striatum.

Authors:  H Matthaei; H Lentzen; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

Review 3.  The tyramine binding site in the central nervous system: an overview.

Authors:  A Vaccari
Journal:  Neurochem Res       Date:  1993-08       Impact factor: 3.996

4.  Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine.

Authors:  A Vaccari; P Saba; G Gessa
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

Review 5.  The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

Authors:  Elizabeth A Mazzio; Fran Close; Karam F A Soliman
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

Review 6.  Nutraceuticals in Parkinson's Disease.

Authors:  Liting Hang; Adeline Henry Basil; Kah-Leong Lim
Journal:  Neuromolecular Med       Date:  2016-05-04       Impact factor: 3.843

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.